NCBIO News
Recent News
BIO and CSBA released a new report on bioscience economic development best practices, “Driving the Bioscience Economy Forward During the COVID-19 Pandemic: Best Practices in State and Regional Economic Development Initiatives.” The report serves as a leading analysis of legislative and regulatory initiatives at the state and regional level for economic development in the bioscience ecosystem.
Read More
Sen. Thom Tillis addressed manufacturing capacity, China, intellectual property protections, workforce development and more with NCBIO members during a legislative forum held online Friday, Jan. 14. He emphasized that he and his staff were eager to hear the concerns, issues and ideas of North Carolina’s life sciences industry.
Read More
Patients and research organizations came together at the NCBIO Clinical Trials Forum to talk about ways to make recruiting and retaining patients easier for clinical trials. The forum was held Wednesday, Dec. 8 at the NC Biotechnology Center.
Read More
Laura Gunter, NCBIO president NCBIO President Laura Gunter has been elected to the Board of Directors of the Council of State Bioscience Associations. Gunter will serve a two-year term beginning 2022. “We are thrilled to announce our new slate of incredibly accomplished and esteemed board leaders for the next exciting phase of CSBA,” said…
Read More
Natacha Janvier has joined NCBIO as the organization’s new membership director. Janvier began her new role on Nov. 15. “We are very excited to have Natacha joining us,” said NCBIO President Laura Gunter. “She has an impressive background in North Carolina’s life sciences industry, and she will be a great asset to our membership recruitment…
Read More
Representatives from the NC Community Colleges’ BioNetwork, the NC Pharmaceutical Services Network, BRITE at NC Central University, NC A&T University and North Carolina State University’s BTEC were all on hand Tuesday, Nov. 16, at the NCBIO Biomanufacturers Forum Meeting to discuss their efforts provide biomanufacturers with a skilled workforce and the state’s citizens with access…
Read More
Jude Samulski, Ph.D., told NCBIO Annual Meeting attendees that the field of gene therapy is the beginning of something that will transform lives forever. Therapies created today for rare diseases will tomorrow generate treatments for common ills like high cholesterol, diabetes and heart failure, he said. Samulski is president and chief scientific officer of AskBio,…
Read More
NCBIO looks back on a year defined by the COVID-19 pandemic and the death of our longtime president and co-founder, Sam Taylor. The organization continued to advocate for state and federal public policies that encourage the growth of life science companies and supports the development of a strong life science workforce.
Read More
Nearly 200 people attended NCBIO’s 2021 Annual Meeting Tuesday, Oct. 5, with almost 120 choosing to be there in person and about 75 opting to participate online. Attendees heard discussions of drug pricing, the challenges of a launching a startup, federal issues affecting the industry and the patient’s role in clinical trials, as well…
Read More
NCBIO and the N.C. Community College System announced the recipients of the newly established Samuel M. Taylor Memorial Life Sciences Scholarship. The Samuel M. Taylor Scholarship was established at the North Carolina Community Colleges Foundation Inc. in memory of Sam Taylor, a founder and president of NCBIO, the trade association that supports life science companies…
Read More